SFV HEALTHCARE

Atara Biotherapeutics Signs Deal With Bayer Worth Up to $610 Million

Atara Biotherapeutics and German pharmaceutical giant Bayer have entered into a strategic collaboration to develop therapies for solid tumors.

MannKind Buys QrumPharma for $3.5 Million

MannKind Corp. announced it has acquired Pennsylvania-based QrumPharma Inc. for $3.5 million in cash and more than 3 million shares of its common stock.

Amgen, McKesson Sign Partnership for Cancer Care

Amgen Inc. and Texas-based health care supply company McKesson Corp. have announced a multi-year, strategic partnership to help bridge gaps in cancer care.

Amgen's Otezla in COVID Therapy Trial

Amgen Inc.’s drug Otezla will appear in a COVID-19 clinical trial, as part of testing efforts by the COVID R&D Alliance consortium of companies.

Amgen Ends Drug Collaboration With Cytokinetics

Amgen Inc. has terminated its collaboration with Bay area startup Cytokinetics.

MannKind Receives Final Milestone Payment for Hypertension Treatment

MannKind Corp. in Westlake Village has received its final $12.5 million milestone payment from United Therapeutics.

Public Health Minor Coming to Cal Lutheran

California Lutheran University in Thousand Oaks will offer a minor in public health starting in January

Revenue Rises at Simulations Plus

Drug modeling software company Simulations Plus Inc. enjoyed an increase in revenue compared to last year, while earnings per share remained flat for the fourth financial quarter.

Ventura County Drops to Purple Tier

Ventura County has dropped to the most restrictive COVID-19 reopening framework tier.

Medtronic Launches Smart Insulin Pen Device

Medical device giant Medtonic has launched InPen, the first FDA-cleared smart insulin pen for diabetes patients needing multiple daily injections.

Providence Joins Anthem Health Plan as Joint Venture Partner

Providence Southern California has joined Anthem Blue Cross’s Vivity Health Plan as a joint venture partner.

MannKind Misses Quarterly Estimate But Afrezza Sales Increase

MannKind Corp. missed third-quarter earnings estimates by 1 cent, but enjoyed a net revenue increase for its flagship drug, inhalable insulin Afrezza.

Medical Supply Company Settles Medicare Fraud Claims

Valley Home Medical Supply Inc. in Canoga Park paid a $565,873 settlement after allegations arose that the company defrauded the federal government's Medicare and Tricare programs.

Providence Cedars-Sinai Holds 'Topping Out' Ceremony at Tarzana Hospital

Providence Cedars-Sinai Tarzana Medical Center held a “topping out” ceremony for its new patient tower.

Amgen Beats Quarterly Estimates, Raises Guidance

Amgen Inc. exceeded analysts estimates for the third quarter, based on results announced by the company.